US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Articles published by Callio Therapeutics

News headline image
Callio Therapeutics Appoints Chris Hassig, PhD, as Chief Scientific Officer
From Callio Therapeutics
Via GlobeNewswire
News headline image
Callio Therapeutics Appoints Zachary Hornby as Chief Executive Officer
From Callio Therapeutics
Via GlobeNewswire
Tickers BOLD
News headline image
Callio Therapeutics to Present Phase 1 Trial Design of CLIO-8221, Novel Dual-Payload ADC, at ASCO 2026
From Callio Therapeutics
Via GlobeNewswire
News headline image
Callio Therapeutics to Present Poster on CLIO-8221, a Novel Dual-Payload Antibody-Drug Conjugate, at AACR 2026
From Callio Therapeutics
Via GlobeNewswire
News headline image
Callio Therapeutics Doses First Patient in Phase I Clinical Trial of Dual-Payload ADC CLIO-8221 in Advanced HER2-Expressing Solid Tumors
From Callio Therapeutics
Via GlobeNewswire